Table 3.
Stakeholder characteristics and stage of device lifecycle.
| Characteristics | Stage of the device development lifecycle |
|---|---|
| Parent/guardian of children with schistosomiasis | Implementation/adoption |
| Community members | Co-creation and Implementation/adoption |
| Community leader | Co-creation and Implementation/adoption |
| Patent Medicine Vendor (PMV) | – |
| Traditional healer | – |
| Market associations | Implementation/adoption |
| Community health committee | Implementation/adoption |
| Community mobilizer | Co-creation and Implementation/adoption |
| Doctors | Co-creation and Implementation/adoption |
| Community Health officers | Co-creation and Implementation/adoption |
| Laboratory scientist/Technician | Co-creation and Implementation/adoption |
| Community Health Extension Workers (CHEW) | Co-creation and Implementation/adoption |
| Primary health care (PHC) coordinator | Co-creation and Implementation/adoption |
| Primary health care board director | Implementation/adoption |
| NTD officer (State and LGA) | Co-creation and Implementation/adoption |
| Disease surveillance and notification Officer (DSNO) (State and LGA) | Co-creation and Implementation/adoption |
| Teachers | – |
| NGO | Co-creation and Implementation/adoption |
| Community-based organization (CBO) | Co-creation and Implementation/adoption |
| Academia | Co-creation and Implementation/adoption |
| Financing | Co-creation and Implementation/adoption |
| Biomedical Engineer | Co-creation and Implementation/adoption |
| National Center for Disease control | Implementation/adoption |
| Media | Implementation/adoption |
| Politicians | Implementation/adoption |
| Equipment suppliers | Implementation/adoption |
| Federal Ministry of Health | Co-creation and Implementation/adoption |
| World Health Organization | Co-creation and Implementation/adoption |